• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算代谢组学揭示苦参碱介导的代谢网络抗肝细胞癌的潜在机制

Computational Metabolomics Reveals the Potential Mechanism of Matrine Mediated Metabolic Network Against Hepatocellular Carcinoma.

作者信息

Wang Kexin, Ye Xiangmin, Yin Chuanhui, Ren Qing, Chen Yupeng, Qin Xuemei, Duan Chuanzhi, Lu Aiping, Gao Li, Guan Daogang

机构信息

National Key Clinical Specialty/Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Neurosurgery Institute, Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Institute of Integrated Bioinformedicine and Translational Science, Hong Kong Baptist University, Hong Kong SAR, China.

出版信息

Front Cell Dev Biol. 2022 Jul 22;10:859236. doi: 10.3389/fcell.2022.859236. eCollection 2022.

DOI:10.3389/fcell.2022.859236
PMID:35938176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9354776/
Abstract

Hepatocellular carcinoma (HCC) is a complex issue in cancer treatment in the world at present. Matrine is the main active ingredient isolated from air and possesses excellent antitumor effects in HCC. However, the specific underlying mechanisms, especially the possible relationships between the anti-HCC effect of matrine and the related metabolic network of HCC, are not yet clear and need further clarification. In this study, an integrative metabolomic-based bioinformatics algorithm was designed to explore the underlying mechanism of matrine on HCC by regulating the metabolic network. Cell clone formation, invasion, and adhesion assay were utilized in HCC cells to evaluate the anti-HCC effect of matrine. A cell metabolomics approach based on LC-MS was used to obtain the differential metabolites and metabolic pathways regulated by matrine. The maximum activity contribution score model was developed and applied to calculate high contribution target genes of matrine, which could regulate a metabolic network based on the coexpression matrix of matrine-regulated metabolic genes and targets. Matrine significantly repressed the clone formation and invasion, enhanced cell-cell adhesion, and hampered cell matrix adhesion in SMMC-7721 cells. Metabolomics results suggested that matrine markedly regulated the abnormal metabolic network of HCC by regulating the level of choline, creatine, valine, spermidine, 4-oxoproline, D-(+)-maltose, L-(-)-methionine, L-phenylalanine, L-pyroglutamic acid, and pyridoxine, which are involved in D-glutamine and D-glutamate metabolism, glycine, serine and threonine metabolism, arginine and proline metabolism, etc. Our proposed metabolomic-based bioinformatics algorithm showed that the regulating metabolic networks of matrine exhibit anti-HCC effects through acting on MMP7, ABCC1, PTGS1, etc. At last, MMP7 and its related target -catenin were validated. Together, the metabolomic-based bioinformatics algorithm reveals the effects of the regulating metabolic networks of matrine in treating HCC relying on the unique characteristics of the multitargets and multipathways of traditional Chinese medicine.

摘要

肝细胞癌(HCC)是目前全球癌症治疗中的一个复杂问题。苦参碱是从苦参中分离出的主要活性成分,对HCC具有优异的抗肿瘤作用。然而,其具体的潜在机制,尤其是苦参碱抗HCC作用与HCC相关代谢网络之间可能的关系,尚不清楚,需要进一步阐明。在本研究中,设计了一种基于整合代谢组学的生物信息学算法,以通过调节代谢网络来探索苦参碱对HCC的潜在作用机制。利用HCC细胞的细胞克隆形成、侵袭和黏附试验来评估苦参碱的抗HCC作用。采用基于液相色谱-质谱联用(LC-MS)的细胞代谢组学方法来获取受苦参碱调节的差异代谢物和代谢途径。开发并应用最大活性贡献得分模型来计算苦参碱的高贡献靶基因,该模型可基于苦参碱调节的代谢基因和靶标的共表达矩阵来调节代谢网络。苦参碱显著抑制SMMC-7721细胞的克隆形成和侵袭,增强细胞间黏附,并阻碍细胞与基质的黏附。代谢组学结果表明,苦参碱通过调节胆碱、肌酸、缬氨酸、亚精胺、4-氧代脯氨酸、D-(+)-麦芽糖、L-(-)-甲硫氨酸、L-苯丙氨酸、L-焦谷氨酸和吡哆醇的水平,显著调节HCC异常的代谢网络,这些代谢物参与D-谷氨酰胺和D-谷氨酸代谢、甘氨酸、丝氨酸和苏氨酸代谢、精氨酸和脯氨酸代谢等。我们提出的基于代谢组学的生物信息学算法表明,苦参碱调节的代谢网络通过作用于基质金属蛋白酶7(MMP7)、ATP结合盒转运蛋白C1(ABCC1)、前列腺素内过氧化物合酶1(PTGS1)等发挥抗HCC作用。最后,对MMP7及其相关靶点β-连环蛋白进行了验证。总之,基于代谢组学的生物信息学算法揭示了苦参碱调节的代谢网络在治疗HCC中的作用,这依赖于中药多靶点和多途径的独特特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/3aaeabff3a57/fcell-10-859236-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/1dc4065c76cd/fcell-10-859236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/6b7e0b0cb21d/fcell-10-859236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/2343fc3709fd/fcell-10-859236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/46dcae5ad229/fcell-10-859236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/929a4508752b/fcell-10-859236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/2af883368b79/fcell-10-859236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/52227ce2f24f/fcell-10-859236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/64aeae344aa9/fcell-10-859236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/7ac50fd2c40b/fcell-10-859236-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/3aaeabff3a57/fcell-10-859236-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/1dc4065c76cd/fcell-10-859236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/6b7e0b0cb21d/fcell-10-859236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/2343fc3709fd/fcell-10-859236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/46dcae5ad229/fcell-10-859236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/929a4508752b/fcell-10-859236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/2af883368b79/fcell-10-859236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/52227ce2f24f/fcell-10-859236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/64aeae344aa9/fcell-10-859236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/7ac50fd2c40b/fcell-10-859236-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f7/9354776/3aaeabff3a57/fcell-10-859236-g010.jpg

相似文献

1
Computational Metabolomics Reveals the Potential Mechanism of Matrine Mediated Metabolic Network Against Hepatocellular Carcinoma.计算代谢组学揭示苦参碱介导的代谢网络抗肝细胞癌的潜在机制
Front Cell Dev Biol. 2022 Jul 22;10:859236. doi: 10.3389/fcell.2022.859236. eCollection 2022.
2
Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.复方苦参注射液通过调控β-catenin/c-Myc 信号通路干预 HCC 代谢重编程及上皮间质转化。
Phytomedicine. 2021 Dec;93:153781. doi: 10.1016/j.phymed.2021.153781. Epub 2021 Sep 27.
3
Antitumor effects of matrine on cancer stem like cells isolated from the human liver cancer SMMC-7721 cell line.苦参碱对从人肝癌SMMC - 7721细胞系分离出的癌干细胞样细胞的抗肿瘤作用。
Oncol Lett. 2018 Feb;15(2):1777-1782. doi: 10.3892/ol.2017.7531. Epub 2017 Dec 5.
4
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.青蒿-苦参及其活性成分对肝癌细胞生物学特性的影响
Evid Based Complement Alternat Med. 2022 Jun 10;2022:8763510. doi: 10.1155/2022/8763510. eCollection 2022.
5
Cell metabolomics study on synergistic anti-hepatocellular carcinoma effect of Aidi injection combined with doxorubicin.细胞代谢组学研究艾迪注射液联合多柔比星协同抗肝癌作用。
Biomed Chromatogr. 2022 Oct;36(10):e5451. doi: 10.1002/bmc.5451. Epub 2022 Aug 8.
6
Matrine inhibits cell growth, migration, invasion and promotes autophagy in hepatocellular carcinoma by regulation of circ_0027345/miR-345-5p/HOXD3 axis.苦参碱通过调控circ_0027345/miR-345-5p/HOXD3轴抑制肝癌细胞的生长、迁移、侵袭并促进自噬。
Cancer Cell Int. 2020 Jun 16;20:246. doi: 10.1186/s12935-020-01293-w. eCollection 2020.
7
- herb pair in the progression of hepatitis, cirrhosis, and hepatocellular carcinoma: a possible mechanisms and relevant therapeutic substances.草药对在肝炎、肝硬化和肝细胞癌进展中的作用:可能的机制及相关治疗物质
Front Pharmacol. 2024 May 27;15:1284752. doi: 10.3389/fphar.2024.1284752. eCollection 2024.
8
Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.苦参碱衍生物WM130通过抑制EGFR/ERK/MMP-2和PTEN/AKT信号通路来抑制肝细胞癌。
Cancer Lett. 2015 Nov 1;368(1):126-134. doi: 10.1016/j.canlet.2015.07.035. Epub 2015 Aug 7.
9
TCM matrine inducescell arrest and apoptosis with recovery expression of the hepato-specific miR122a in human hepatocellular carcinomaHep G2cell line.中药苦参碱诱导人肝癌Hep G2细胞系细胞停滞和凋亡,并使肝特异性miR122a的表达恢复。
Int J Clin Exp Med. 2015 Jun 15;8(6):9004-12. eCollection 2015.
10
Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.通过定量分析、网络分析和实验验证揭示复方苦参注射液抗肝癌的抗癌机制。
Sci Rep. 2018 Jan 12;8(1):624. doi: 10.1038/s41598-017-18325-7.

引用本文的文献

1
Quantitative Proteomics Reveal the Role of Matrine in Regulating Lipid Metabolism.定量蛋白质组学揭示苦参碱在调节脂质代谢中的作用。
ACS Omega. 2024 May 29;9(23):24308-24320. doi: 10.1021/acsomega.3c09983. eCollection 2024 Jun 11.

本文引用的文献

1
Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.复方苦参注射液通过调控β-catenin/c-Myc 信号通路干预 HCC 代谢重编程及上皮间质转化。
Phytomedicine. 2021 Dec;93:153781. doi: 10.1016/j.phymed.2021.153781. Epub 2021 Sep 27.
2
Cancer metabolism: looking forward.癌症代谢:展望未来。
Nat Rev Cancer. 2021 Oct;21(10):669-680. doi: 10.1038/s41568-021-00378-6. Epub 2021 Jul 16.
3
A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
一种代谢数据驱动的系统药理学策略,用于解码和验证复方苦参注射液抗肝癌的作用机制。
J Ethnopharmacol. 2021 Jun 28;274:114043. doi: 10.1016/j.jep.2021.114043. Epub 2021 Mar 20.
4
New advances in the diagnosis and management of hepatocellular carcinoma.肝细胞癌的诊断与治疗新进展。
BMJ. 2020 Oct 26;371:m3544. doi: 10.1136/bmj.m3544.
5
Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.靶向线粒体代谢网络:癌症治疗的一种有前途的策略。
Int J Mol Sci. 2020 Aug 21;21(17):6014. doi: 10.3390/ijms21176014.
6
Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma.从慢性乙型肝炎到肝细胞癌的血浆代谢谱、特征和酶分析。
Aging (Albany NY). 2020 Jul 23;12(14):14949-14965. doi: 10.18632/aging.103554.
7
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.索拉非尼耐药在肝细胞癌中的机制:理论基础和治疗方面。
Signal Transduct Target Ther. 2020 Jun 10;5(1):87. doi: 10.1038/s41392-020-0187-x.
8
Creatine metabolism: energy homeostasis, immunity and cancer biology.肌酸代谢:能量平衡、免疫和癌症生物学。
Nat Rev Endocrinol. 2020 Aug;16(8):421-436. doi: 10.1038/s41574-020-0365-5. Epub 2020 Jun 3.
9
Baicalein protects PC12 cells from Aβ-induced cytotoxicity via inhibition of apoptosis and metabolic disorders.黄芩素通过抑制细胞凋亡和代谢紊乱来保护 PC12 细胞免受 Aβ诱导的细胞毒性。
Life Sci. 2020 May 1;248:117471. doi: 10.1016/j.lfs.2020.117471. Epub 2020 Feb 26.
10
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.基质金属蛋白酶在肝癌上皮-间质转化中的作用。
Anal Cell Pathol (Amst). 2019 Nov 26;2019:9423907. doi: 10.1155/2019/9423907. eCollection 2019.